2:00 PM - 4:30 PM
[28Q-pm043] Combination with EGFR-TKI and Trametinib, a MEK inhibitor, overcomes resistance to EGFR-TKI in NSCLC
A password that applicants have been notified of is required to view abstracts.
If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.
We will reply after confirming that you were a participant.
Thank you for your understanding.